Literature DB >> 9477693

Histopathology of human American cutaneous leishmaniasis before and after treatment.

A C Botelho1, W L Tafuri, O Genaro, W Mayrink.   

Abstract

Chemical therapy for the treatment of leishmaniasis is still inadequate, and a number of drugs and therapeutic programs are being tested. Besides treatment, the ultimate goal is an effective cure, and histopathological analyses of the lesion cicatrices constitute an important measure of treatment success, or otherwise, in this respect. In this paper, we describe histopathological patterns in cases of American cutaneous leishmaniasis in 32 patients from the municipality of Caratinga, Minas Gerais, Brazil, before and after treatment with the following therapeutic methods: 1) leishvacin + glucantime; 2) leishvacin + BCG associated with glucantime; 3) glucantime; 4) leishvacin + BCG. Lesion fragments were collected from all patients by biopsy prior to, and approximately 30 days after, each treatment which resulted in a clinical diagnosis of cure. Following the analysis of slides, the preparations were described from a histopathological point of view and grouped taking into account the prevalence or significance of the characteristic elements. This process resulted in the following classification: 1. exudative reaction (ER); 2. exudative giant cell reaction (EGCR); 3. exudative productive reaction (EPR); 4. exudative productive giant cell reaction (EPGCR); 5. exudative productive necrotic reaction (EPNR); 6. necrotic exudative reaction (NER); 7. productive exudative reaction (PER), 8. productive giant cell reaction (PGCR); 9. productive exudative giant cell reaction (PEGCR); 10. productive exudative giant cell granulomatous reaction (PEGCGR); 11. productive reaction (PR) and 12. productive cicatricial (cure) reaction (PCR). After this analysis, it was noted that clinical cure did not always coincide with histopathological cure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9477693     DOI: 10.1590/s0037-86821998000100002

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  4 in total

1.  MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis.

Authors:  Diogo Oliveira-Maciel; Júlio Souza Dos-Santos; Gabriel Oliveira-Silva; Mirian França de Mello; Alessandra Marcia da Fonseca-Martins; Monique Pacheco Duarte Carneiro; Tadeu Diniz Ramos; Luan Firmino-Cruz; Daniel Claudio Oliveira Gomes; Bartira Rossi-Bergmann; Herbert Leonel de Matos Guedes
Journal:  Microorganisms       Date:  2021-06-11

2.  Histopathological and immunohistochemical aspects of American cutaneous leishmaniasis before and after different treatments.

Authors:  Agostinho Gonçalves Viana; Wilson Mayrink; Carlos Alberto de Carvalho Fraga; Luciana Maria Silva; Patrícia Luciana Batista Domingos; Paulo Rogério Ferreti Bonan; Alfredo Maurício Batista de Paula; Ana Cristina de Carvalho Botelho
Journal:  An Bras Dermatol       Date:  2013 Jan-Feb       Impact factor: 1.896

3.  American tegumentary leishmaniasis: effectiveness of an immunohistochemical protocol for the detection of Leishmania in skin.

Authors:  Cibele Fontes Alves; Cintia Fontes Alves; Maria Marta Figueiredo; Carolina Carvalho Souza; George Luiz Lins Machado-Coelho; Maria Norma Melo; Washington Luiz Tafuri; Pedro Raso; Rodrigo Pedro Soares; Wagner Luiz Tafuri
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

4.  American tegumentary leishmaniasis: correlations among immunological, histopathological and clinical parameters.

Authors:  Ana Luiza Grizzo Peres Martins; Jaison Antonio Barreto; José Roberto Pereira Lauris; Ana Claudia Grizzo Peres Martins
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.